IRulya Therapeutics, Inc. (IRLA)
39.14
-0.64
(-1.61%)
USD |
NASDAQ |
Nov 13, 11:23
IRulya Therapeutics Net Income (Annual) : -83.98M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -83.98M |
| December 31, 2024 | -56.83M |
| December 31, 2023 | -31.38M |
| December 31, 2022 | -51.66M |
| December 31, 2021 | -89.94M |
| Date | Value |
|---|---|
| December 31, 2020 | -76.85M |
| December 31, 2019 | -36.98M |
| December 31, 2018 | -12.48M |
| December 31, 2017 | -12.24M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Korsana Biosciences, Inc. | -3.528M |
| PepGen Inc. | -89.66M |
| Q32 Bio, Inc. | 29.82M |
| Bridgebio Oncology Therapeutics, Inc. | -134.04M |
| Arrowhead Pharmaceuticals, Inc. | 30.11M |